Host Genetic Determinants of Human Immunodeficiency Virus Infection and Disease Progression in Children

被引:31
|
作者
Singh, Kumud K. [1 ]
Spector, Stephen A. [1 ]
机构
[1] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA
关键词
MANNOSE-BINDING LECTIN; HIV-1 VERTICAL TRANSMISSION; AGE-DEPENDENT ASSOCIATION; SINGLE-DOSE NEVIRAPINE; HIV-1-INFECTED CHILDREN; HIV-1-RELATED DISEASE; CLINICAL-SIGNIFICANCE; RECEPTOR CX(3)CR1; TYPE-1; INFECTION; AIDS PROGRESSION;
D O I
10.1203/PDR.0b013e31819dca03
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Increasing data support host genetic factors as an important determinants of human immunodeficiency virus type-1 (HIV-1) susceptibility, mother-to-child transmission (MTCT), and disease progression. Of these genetic mediators, those impacting innate and adaptive immune responses seem to play a critical role in viral infectivity and pathogenesis. During primary infection, CCR5 using virus is predominantly transmitted and polymorphisms that affect the expression of CCR5 alter the risk for MTCT and rate of disease. Chemokines that naturally bind to coreceptors alter infectivity and viral pathogenesis. Additional genes that affect innate immunity including those encoding for MBL2 and those modulating the adaptive immune response including CX(3)CR1 and human leukocyte antigen types can significantly modify susceptibility and response to HIV-1 infection. As young children develop, the dependence on certain arms of the immune system varies and can alter the effect of genetic variants. Additionally, host generic factors may alter the response to antiretrovirals. Finally, because HIV-infected children progress more rapidly than adults and have fewer back-ground cofactors, such as drug use and coinfections. the effects of host factors on HIV-1 disease may be more clearly identified. In this review, we summarize available data on the impact of host genetics on MTCT and disease progression of HIV-infected children. (Pediatr Res 65: 55R-63R, 2009)
引用
收藏
页码:55R / 63R
页数:9
相关论文
共 50 条
  • [21] Nutrition and human immunodeficiency virus infection in children
    Eley, B
    Hussey, G
    SOUTH AFRICAN MEDICAL JOURNAL, 1999, 89 (02): : 190 - 195
  • [22] HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN CHILDREN
    HOERNLE, EH
    REID, TE
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (09) : 961 - 979
  • [23] Pain and human immunodeficiency virus infection in children
    Yaster, M
    Schechter, N
    PEDIATRICS, 1996, 98 (03) : 455 - 456
  • [24] HUMAN IMMUNODEFICIENCY VIRUS-INFECTION IN CHILDREN
    FALLOON, J
    EDDY, J
    WIENER, L
    PIZZO, PA
    JOURNAL OF PEDIATRICS, 1989, 114 (01): : 1 - 30
  • [25] Informing children of their human immunodeficiency virus infection
    Schonfeld, DJ
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 1997, 151 (10): : 976 - 977
  • [26] Tuberculosis in children with human immunodeficiency virus infection
    Chintu, C
    Mwaba, P
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2005, 9 (05) : 477 - 484
  • [27] Education of children with human immunodeficiency virus infection
    Wilfert, CM
    Kline, MW
    Futterman, D
    Havens, PL
    King, S
    Mofenson, LM
    Scott, GB
    Wara, DW
    Whitley-Williams, PN
    PEDIATRICS, 2000, 105 (06) : 1358 - 1360
  • [28] Slow progression of human immunodeficiency virus and hepatitis C virus disease in a cohort of coinfected children
    Micheloud, Danela
    Jensen, Julia
    Bellon, Jose M.
    Gurbindo, Dolores
    de Jose, Isabel
    Moreno, David
    Ramos, Jose T.
    Munoz-Fernandez, Ma Angeles
    Resino, Salvador
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2007, 26 (09) : 846 - 849
  • [29] Host genetic variations associated with disease progression in chronic hepatitis C virus infection
    Matsuura, Kentaro
    Tanaka, Yasuhito
    HEPATOLOGY RESEARCH, 2018, 48 (02) : 127 - 133
  • [30] INFLUENCE OF NEUROLOGIC MANIFESTATIONS OF PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION ON DISEASE PROGRESSION
    BOUFASSA, F
    BACHMEYER, C
    CARRE, N
    DEVEAU, C
    PERSOZ, A
    JADAND, C
    SERENI, D
    BUCQUET, D
    ROUZIOUX, C
    DELLAMONICA, P
    GALLAIS, H
    DELFRAISSY, JF
    LEFRERE, JJ
    CASSUTO, JP
    DUPONT, B
    VITTECOQ, D
    HERSON, S
    GASTAUT, JA
    VILDE, JL
    KATLAMA, C
    SOBEL, A
    DUVAL, J
    KAZATCHKINE, M
    LEBRAS, P
    EVEN, P
    GUILLEVIN, L
    MEYER, L
    DEVEAU, C
    JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (05): : 1190 - 1195